Spl-zonisamide-figure1 (Spl Zonisamide Figure1)
Zonisamide Capsule
Product Images NDC 62756-259
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Zonisamide (NDC 62756-259). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Spl-zonisamide-label-100mg (Spl Zonisamide Label 100mg)
Each capsule of Zonisamide, USP contains 100 mg. The recommended dosage is not provided and needs to be referred to the package insert. The capsules should be stored in a dry place, protected from light, at a temperature of 26°C (77°F) with excursions permitted to 15°-30°C (59°-86°F) [see USP Controlled Room Temperature]. The drug is available in a pack of 30 capsules and requires a prescription. The pharmacist is required to provide an extra medication guide separately to each patient. The manufacturer and distributor of the capsules are Sun Pharmaceutical Industries, Inc. and Sun Pharmaceutical Industries Ltd., respectively, located in the U.S. and India. The batch number is 15, 072014.*
Spl-zonisamide-label-25mg (Spl Zonisamide Label 25mg)
Spl-zonisamide-label-50mg (Spl Zonisamide Label 50mg)
This is a medication called Zonisamide Capsules, each containing 50 mg of zonisamide. The recommended dosage is not specified, and the package insert should be consulted for full prescribing information. The medicine should be stored in a dry place at a temperature between 15°C to 30°C (59°F to 86°F) and protected from light. The NDC number is 62756-259-01, and the medication is distributed by Sun Pharmaceutical Industries, Inc. The manufacturer is Sun Pharmaceutical Industries Ltd. located in Halol-Baroda Highway, Halol-389 350, Gujarat, India. The medicine should only be dispensed with a medication guide provided separately to each patient. The rest of the text seems to be production information and is not relevant for patients.*
Spl-zonisamide-structure (Spl Zonisamide Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
